India Cements Capital Intrinsic Value

India Cements Capital (INDCEMCAP) median intrinsic value is ₹6.55 from 2 valuation models (range ₹4–₹7), vs current price ₹14.67 — -55.4% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse INDCEMCAP cash flow statement for revenue, profit, balance sheet and cash flow data.

Current Stock Price
₹14.67
Primary Intrinsic Value
₹6.55
Market Cap
₹32.3 Cr
-55.4% Downside
Median Value
₹6.55
Value Range
₹4 - ₹7
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

INDCEMCAP Valuation Methods Summary — DCF, Graham Number & P/E

India Cements Capital intrinsic value across 2 models vs current price ₹14.67 — upside/downside and value range per method. For current market price and key ratios, visit India Cements Capital share price today.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹6.55 ₹5.89 - ₹7.21 -55.4% Book Value/Share: ₹8.18, P/B: 0.8x
Revenue Multiple Method revenue ₹4.40 ₹3.96 - ₹4.84 -70.0% Revenue/Share: ₹1.82, P/S: 1.0x
Method Types: Earnings Asset DCF Growth Dividend Conservative

INDCEMCAP Intrinsic Value vs Market Price — All Valuation Models

India Cements Capital fair value range ₹4–₹7 vs current market price ₹14.67 across 2 valuation models. Also explore INDCEMCAP price trends to track price trends across different timeframes.

INDCEMCAP Intrinsic Value Analysis — Undervalued or Overvalued?

India Cements Capital median intrinsic value ₹6.55, current price ₹14.67 — Trading Above Calculated Value by 55.4%, margin of safety -100.0%.

What is the intrinsic value of INDCEMCAP?

Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of India Cements Capital (INDCEMCAP) is ₹6.55 (median value). With the current market price of ₹14.67, this represents a -55.4% variance from our estimated fair value.

The valuation range spans from ₹4.40 to ₹6.55, indicating ₹4.40 - ₹6.55.

Is INDCEMCAP undervalued or overvalued?

Based on our multi-method analysis, India Cements Capital (INDCEMCAP) appears to be trading above calculated value by approximately 55.4%.

INDCEMCAP Financial Health — Key Ratios vs Industry Benchmarks

India Cements Capital financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 0.51 Industry Standard: 2.0+ Below 1.5 Measures short-term liquidity capacity
Operating Margin -13.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.06x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

INDCEMCAP Cash Flow Quality — Operating & Free Cash Flow

India Cements Capital operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹-2 Cr ₹-2 Cr Negative Cash Flow 3/10
March 2021 ₹2 Cr ₹1 Cr Positive Free Cash Flow 7/10